Mads H. Haugen

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Liver X receptors induce antiproliferative effects in basal‐like breast cancer”.

Liver X receptors induce antiproliferative effects in basal‐like breast cancer

Molecular Oncology(2023)10.1002/1878-0261.13476

N/A

0.208DataRank · unranked

3 citations

Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, Lisa Svartdal Normann, Abhilash Pandya, Lise‐Lotte Vedin +10 more

AXL inhibition improves BRAF-targeted treatment in melanoma

Scientific Reports(2022)10.1038/s41598-022-09078-z

N/A

0DataRank · unranked

45 citations

Karianne G. Fleten, Mads H. Haugen, Nikolai Engedal, Christina Sveen, Inger Nina Farstad +5 more

miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy

Breast Cancer Targets and Therapy(2022)10.2147/bctt.s338404

N/A

0DataRank · unranked

16 citations

Mads H. Haugen, Miriam R. R. Aure, Vessela N. Kristensen, Gunhild M. Mælandsmo, Kristine Kleivi Sahlberg +1 more

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

PLoS ONE(2023)10.1371/journal.pone.0280507

N/A

0DataRank · unranked

7 citations

Mads H. Haugen, Vesa Hongisto, Miriam R. R. Aure, Suvi‐Katri Leivonen, Vessela N. Kristensen +5 more